Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

Identifieur interne : 000300 ( France/Analysis ); précédent : 000299; suivant : 000301

Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

Auteurs : A. Delluc [France] ; N. Limal [France] ; X. Puéchal [France] ; C. Francès [France] ; J C Piette [France] ; P. Cacoub [France]

Source :

RBID : ISTEX:E7B93E2E4D5F0EDDEA3C9A407CA77705BC3BC8E3

English descriptors


Url:
DOI: 10.1136/ard.2006.068254


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:E7B93E2E4D5F0EDDEA3C9A407CA77705BC3BC8E3

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome</title>
<author>
<name sortKey="Delluc, A" sort="Delluc, A" uniqKey="Delluc A" first="A" last="Delluc">A. Delluc</name>
</author>
<author>
<name sortKey="Limal, N" sort="Limal, N" uniqKey="Limal N" first="N" last="Limal">N. Limal</name>
</author>
<author>
<name sortKey="Puechal, X" sort="Puechal, X" uniqKey="Puechal X" first="X" last="Puéchal">X. Puéchal</name>
</author>
<author>
<name sortKey="Frances, C" sort="Frances, C" uniqKey="Frances C" first="C" last="Francès">C. Francès</name>
</author>
<author>
<name sortKey="Piette, J C" sort="Piette, J C" uniqKey="Piette J" first="J C" last="Piette">J C Piette</name>
</author>
<author>
<name sortKey="Cacoub, P" sort="Cacoub, P" uniqKey="Cacoub P" first="P" last="Cacoub">P. Cacoub</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E7B93E2E4D5F0EDDEA3C9A407CA77705BC3BC8E3</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1136/ard.2006.068254</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-H7PRWPXM-3/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001B71</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B71</idno>
<idno type="wicri:Area/Istex/Curation">001B71</idno>
<idno type="wicri:Area/Istex/Checkpoint">000913</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000913</idno>
<idno type="wicri:doubleKey">0003-4967:2008:Delluc A:efficacy:of:anakinra</idno>
<idno type="wicri:Area/Main/Merge">001A16</idno>
<idno type="wicri:Area/Main/Curation">001A08</idno>
<idno type="wicri:Area/Main/Exploration">001A08</idno>
<idno type="wicri:Area/France/Extraction">000300</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome</title>
<author>
<name sortKey="Delluc, A" sort="Delluc, A" uniqKey="Delluc A" first="A" last="Delluc">A. Delluc</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Limal, N" sort="Limal, N" uniqKey="Limal N" first="N" last="Limal">N. Limal</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Puechal, X" sort="Puechal, X" uniqKey="Puechal X" first="X" last="Puéchal">X. Puéchal</name>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Rhumatologie, Centre Hospitalier du Mans</wicri:regionArea>
<wicri:noRegion>Centre Hospitalier du Mans</wicri:noRegion>
<wicri:noRegion>Centre Hospitalier du Mans</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Frances, C" sort="Frances, C" uniqKey="Frances C" first="C" last="Francès">C. Francès</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Piette, J C" sort="Piette, J C" uniqKey="Piette J" first="J C" last="Piette">J C Piette</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cacoub, P" sort="Cacoub, P" uniqKey="Cacoub P" first="P" last="Cacoub">P. Cacoub</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Université Pierre et Marie Curie Paris 6, CNRS, UMR 7087, Paris, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the Rheumatic Diseases</title>
<title level="j" type="abbrev">Ann Rheum Dis</title>
<idno type="ISSN">0003-4967</idno>
<idno type="eISSN">1468-2060</idno>
<imprint>
<publisher>BMJ Publishing Group Ltd and European League Against Rheumatism</publisher>
<date type="published" when="2008-02">2008-02</date>
<biblScope unit="volume">67</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="278">278</biblScope>
</imprint>
<idno type="ISSN">0003-4967</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0003-4967</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Acad dermatol</term>
<term>Adalimumab</term>
<term>Adalimumab refutes</term>
<term>Alveolar lung condensations</term>
<term>Anakinra</term>
<term>Anakinra introduction</term>
<term>Antagonist</term>
<term>Antimalarial</term>
<term>Apoptosis</term>
<term>April</term>
<term>Arthritis rheum bourke</term>
<term>Azathioprine</term>
<term>Bernier</term>
<term>Biochem</term>
<term>Biochem pharmacol lagneaux</term>
<term>Bourke</term>
<term>Bron</term>
<term>Cacoub</term>
<term>Cacoub1</term>
<term>Carlier</term>
<term>Case report</term>
<term>Cell type</term>
<term>Centre hospitalier</term>
<term>Characterised</term>
<term>Chemoattractant</term>
<term>Chemokines</term>
<term>Clin</term>
<term>Clin rheumatol</term>
<term>Cnrs</term>
<term>Colchicine</term>
<term>Control anakinra</term>
<term>Corticosteroid</term>
<term>Costenbader</term>
<term>Cyclophosphamide</term>
<term>Cytokine</term>
<term>Delforge</term>
<term>Dense neutrophilic</term>
<term>Dermal</term>
<term>Dermatol</term>
<term>Dermatol dinarello</term>
<term>Dermatosis</term>
<term>Dinarello</term>
<term>Disease activity</term>
<term>Disease concepts</term>
<term>Disulone</term>
<term>Dose prednisone</term>
<term>Dramatic efficacy</term>
<term>Drug effects</term>
<term>Drug responses</term>
<term>Early induction</term>
<term>Egurbide</term>
<term>Engl</term>
<term>Epidermal</term>
<term>Epidermal staining</term>
<term>Erythematosus</term>
<term>Erythematous</term>
<term>Erythrocyte</term>
<term>Erythrocyte sedimentation rate</term>
<term>Experimental breast cancer agents</term>
<term>February</term>
<term>First time</term>
<term>France correspondence</term>
<term>Garmendia</term>
<term>Giasuddin</term>
<term>Good efficacy</term>
<term>Haematol</term>
<term>Haematol efficacy</term>
<term>Haemolysis</term>
<term>Histopathologic</term>
<term>Histopathologic evidence</term>
<term>Hopital</term>
<term>Hopital service</term>
<term>Hospitalier</term>
<term>Human breast cancer cell model</term>
<term>Human receptor antagonist</term>
<term>Hydroxychloroquine</term>
<term>Immortal time bias</term>
<term>Immunohistochemical</term>
<term>Immunohistochemical study</term>
<term>Immunosuppressive</term>
<term>Immunosuppressive drugs</term>
<term>Increase production</term>
<term>Inflammation</term>
<term>Inflammatory</term>
<term>Inflammatory disease</term>
<term>Interleukin</term>
<term>January</term>
<term>July</term>
<term>Kinereth</term>
<term>Kurzrock</term>
<term>Laboratory signs</term>
<term>Lagneaux</term>
<term>Lesion</term>
<term>Leukaemia</term>
<term>Lower staining</term>
<term>Lupus</term>
<term>Lymphocyte</term>
<term>Lymphocytic</term>
<term>Lymphocytic leukaemia cells</term>
<term>Macrophage</term>
<term>Major pathophysiological role</term>
<term>Many worlds</term>
<term>Marie curie paris</term>
<term>Martinezberriotxoa</term>
<term>Martirosyan</term>
<term>Massy</term>
<term>Mature neutrophils</term>
<term>Medecine</term>
<term>Mediator</term>
<term>Methotrexate</term>
<term>Natural inhibitor</term>
<term>Neutrophil</term>
<term>Neutrophilia</term>
<term>Neutrophilic</term>
<term>Neutrophilic dermatosis characterised</term>
<term>Nitric</term>
<term>Nitric oxide</term>
<term>Normal control subjects</term>
<term>Observational studies</term>
<term>Online</term>
<term>Pathological study</term>
<term>Pathophysiological</term>
<term>Pharmacoepidemiol</term>
<term>Pharmacoepidemiol drug</term>
<term>Pharmacol</term>
<term>Pijoan</term>
<term>Possible mediator</term>
<term>Previous studies</term>
<term>Prostaglandin</term>
<term>Pulmonary involvement</term>
<term>Quinolines</term>
<term>Radiological</term>
<term>Radiological remission</term>
<term>Randomised</term>
<term>Receptor</term>
<term>Receptor antagonist</term>
<term>Receptor antagonist anakinra kinereth</term>
<term>Recombinant</term>
<term>Recombinant form</term>
<term>Recurrent fever</term>
<term>Refractory</term>
<term>Refutes</term>
<term>Remission</term>
<term>Remodelling</term>
<term>Rheum</term>
<term>Rheumatol</term>
<term>Rhumatologie</term>
<term>Right flank</term>
<term>Same treatment regimen</term>
<term>Secrete</term>
<term>September</term>
<term>Serum levels</term>
<term>Severe haemolysis</term>
<term>Significant reduction</term>
<term>Skin lesions</term>
<term>Specific intervention</term>
<term>Specific neutrophil chemoattractant</term>
<term>Strobl</term>
<term>Study5</term>
<term>Subcutaneously</term>
<term>Suissa</term>
<term>Survival factors</term>
<term>Syndrome</term>
<term>Systemic lupus erythematosus</term>
<term>Tender erythematous skin lesions</term>
<term>Tissue remodelling</term>
<term>Tumour</term>
<term>Tumour necrosis factor</term>
<term>Type1</term>
<term>Type1 receptor</term>
<term>Ugarte</term>
<term>Universite pierre</term>
<term>Various functions</term>
<term>White blood cells</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<region name="Île-de-France">
<name sortKey="Delluc, A" sort="Delluc, A" uniqKey="Delluc A" first="A" last="Delluc">A. Delluc</name>
</region>
<name sortKey="Cacoub, P" sort="Cacoub, P" uniqKey="Cacoub P" first="P" last="Cacoub">P. Cacoub</name>
<name sortKey="Frances, C" sort="Frances, C" uniqKey="Frances C" first="C" last="Francès">C. Francès</name>
<name sortKey="Limal, N" sort="Limal, N" uniqKey="Limal N" first="N" last="Limal">N. Limal</name>
<name sortKey="Piette, J C" sort="Piette, J C" uniqKey="Piette J" first="J C" last="Piette">J C Piette</name>
<name sortKey="Puechal, X" sort="Puechal, X" uniqKey="Puechal X" first="X" last="Puéchal">X. Puéchal</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000300 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000300 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    RBID
   |clé=     ISTEX:E7B93E2E4D5F0EDDEA3C9A407CA77705BC3BC8E3
   |texte=   Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021